AJP - Lung Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol 276: L776-L785, 1999;
1040-0605/99 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by George, C. L. S.
Right arrow Articles by Abraham, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by George, C. L. S.
Right arrow Articles by Abraham, E.
Vol. 276, Issue 5, L776-L785, May 1999

Effects of lisofylline on hyperoxia-induced lung injury

Caroline L. S. George1, Giamila Fantuzzi2, Stuart Bursten3, Laura Leer3, and Edward Abraham4

Departments of 1 Pediatric Critical Care, 2 Infectious Disease, and 4 Pulmonary Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80262; and 3 Cell Therapeutics, Inc., Seattle, Washington 98119

Lisofylline [1-(5R-hydroxyhexyl)-3,7-dimethylxanthine] decreases lipid peroxidation in vitro and in vivo suppresses proinflammatory cytokine expression in models of lung injury due to sepsis, blood loss, and oxidative damage. In the present experiments, we used a murine hyperoxia model to examine the effects of lisofylline on the activation of nuclear transcriptional regulatory factors [nuclear factor-kappa B and cAMP response element binding protein (CREB)], the expression of proinflammatory cytokines in the lungs, and the circulating levels of oxidized free fatty acids as well as on hyperoxia-induced lung injury and mortality. Treatment with lisofylline inhibited hyperoxia-associated increases in tumor necrosis factor-alpha , interleukin-1beta , and interleukin-6 in the lungs as well as decreased the levels of hyperoxia-induced serum-oxidized free fatty acids. Although hyperoxic exposure produced activation of both nuclear factor-kappa B and CREB in lung cell populations, only CREB activation was reduced in the mice treated with lisofylline. Lisofylline diminished hyperoxia-associated increases in lung wet-to-dry weight ratios and improved survival in animals exposed to hyperoxia. These results suggest that lisofylline ameliorates hyperoxia-induced lung injury and mortality through inhibiting CREB activation, membrane oxidation, and proinflammatory cytokine expression in the lungs.

cytokine expression; nuclear factor-kappa B; adenosine 3',5'-cyclic monophosphate response element binding protein; lipid oxidation


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
H. Pei, J. Gu, P.-R. Thimmalapura, A. Mison, and J. L. Nadler
Activation of the 12-lipoxygenase and signal transducer and activator of transcription pathway during neointima formation in a model of the metabolic syndrome
Am J Physiol Endocrinol Metab, January 1, 2006; 290(1): E92 - E102.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. Buckley, L. Barsky, K. Weinberg, and D. Warburton
In vivo inosine protects alveolar epithelial type 2 cells against hyperoxia-induced DNA damage through MAP kinase signaling
Am J Physiol Lung Cell Mol Physiol, March 1, 2005; 288(3): L569 - L575.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
C. T. D'Angio, M. B. LoMonaco, C. J. Johnston, C. K. Reed, and J. N. Finkelstein
Differential roles for NF-{kappa}B in endotoxin and oxygen induction of interleukin-8 in the macrophage
Am J Physiol Lung Cell Mol Physiol, January 1, 2004; 286(1): L30 - L36.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online